Bifidobacterium pseudocatenulatum CECT 7765 supplementation improves inflammatory status in insulin-resistant obese children
- PMID: 30251018
- DOI: 10.1007/s00394-018-1828-5
Bifidobacterium pseudocatenulatum CECT 7765 supplementation improves inflammatory status in insulin-resistant obese children
Abstract
Purpose: The relationships between gut microbiota and obesity-related co-morbidities have been increasingly recognized. Low-grade inflammation may be the main factor in the pathogenesis of such disorders. We investigated the effect of the potential probiotic Bifidobacterium pseudocatenulatum CECT 7765 on cardiometabolic risk factors, inflammatory cytokines and gut microbiota composition in obese children with insulin resistance.
Methods: The study included 48 obese children (10-15 years old) with insulin resistance. They received dietary advice and were assigned to take the capsules with or without probiotic (109-10 CFU) daily for 13 weeks. Clinical, biochemical and gut microbiome measurements were made at baseline and at the end of the intervention.
Results: There was a significant improvement in body mass index in all children after the intervention, suggesting that weight changes are related to the dietary advice. A significant decrease in circulating high-sensitive C-reactive protein (P = 0.026) and monocyte chemoattractant protein-1 (P = 0.032) and an increase in high-density lipoprotein cholesterol (P = 0.035) and omentin-1 (P = 0.023) in children receiving probiotic supplementation were observed compared to the control group. Regarding gut microbiota, probiotic administration significantly increased the proportion of the Rikenellaceae family members, particularly of the Alistipes genus.
Conclusions: The beneficial effects of the intervention on inflammatory markers and lipid profile suggest that B. pseudocatenulatum CECT 7765 intake together with dietary recommendations can improve inflammatory status in children with obesity and insulin resistance. These effects are parallel to increases in bacterial groups associated with a lean phenotype. The modulation of gut microbiota with probiotic supplementation can be considered an effective tool to ameliorate some obesity-related disorders in children.
Keywords: Bifidobacterium pseudocatenulatum; Children obesity; Gut microbiota; Monocyte chemoattractant protein-1; Omentin-1; Probiotics.
Similar articles
-
Bifidobacterium pseudocatenulatum CECT 7765 supplementation restores altered vascular function in an experimental model of obese mice.Int J Med Sci. 2017 Apr 8;14(5):444-451. doi: 10.7150/ijms.18354. eCollection 2017. Int J Med Sci. 2017. PMID: 28539820 Free PMC article.
-
Bifidobacterium pseudocatenulatum CECT 7765 reverses the adverse effects of diet-induced obesity through the gut-bone axis.Bone. 2020 Dec;141:115580. doi: 10.1016/j.bone.2020.115580. Epub 2020 Aug 11. Bone. 2020. PMID: 32795675
-
Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice.PLoS One. 2015 Jul 10;10(7):e0126976. doi: 10.1371/journal.pone.0126976. eCollection 2015. PLoS One. 2015. PMID: 26161548 Free PMC article.
-
A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110187. doi: 10.1016/j.pnpbp.2020.110187. Epub 2020 Dec 1. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33271210 Free PMC article.
-
Probiotic Strains and Intervention Total Doses for Modulating Obesity-Related Microbiota Dysbiosis: A Systematic Review and Meta-analysis.Nutrients. 2020 Jun 29;12(7):1921. doi: 10.3390/nu12071921. Nutrients. 2020. PMID: 32610476 Free PMC article.
Cited by
-
Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study.Nutrients. 2021 Feb 8;13(2):558. doi: 10.3390/nu13020558. Nutrients. 2021. PMID: 33567701 Free PMC article. Clinical Trial.
-
Obesity and the gut microbiota: implications of neuroendocrine and immune signaling.FEBS J. 2025 Mar;292(6):1397-1420. doi: 10.1111/febs.17249. Epub 2024 Aug 19. FEBS J. 2025. PMID: 39159270 Free PMC article. Review.
-
Effects of gut microbiome-targeted therapies on cardiometabolic outcomes in children and adolescents: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 Jul 31;99(31):e21612. doi: 10.1097/MD.0000000000021612. Medicine (Baltimore). 2020. PMID: 32756217 Free PMC article.
-
Metagenomic study of the gut microbiota associated with cow milk consumption in Chinese peri-/postmenopausal women.Front Microbiol. 2022 Aug 16;13:957885. doi: 10.3389/fmicb.2022.957885. eCollection 2022. Front Microbiol. 2022. PMID: 36051762 Free PMC article.
-
Metagenomic analysis reveals distinct changes in the gut microbiome of obese Chinese children.BMC Genomics. 2023 Nov 29;24(1):721. doi: 10.1186/s12864-023-09805-4. BMC Genomics. 2023. PMID: 38031016 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials